NCT02556060View on ClinicalTrials.gov

Lamotrigine for Ketamine Dependence Trial

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

May 1, 2017

Study Completion Date

May 1, 2017

Conditions
Addiction
Interventions
DRUG

Lamotrigine

Starting from 25 mg/day in the first week, then titrated up to 200 mg/day for 12 weeks

DRUG

Placebo

Same dosing schedule as study drug

Trial Locations (1)

110

Taipei City Hospital and Psychiatric Center, Taipei

All Listed Sponsors
collaborator

Chang Gung Memorial Hospital

OTHER

lead

Taipei City Hospital

OTHER_GOV

NCT02556060 - Lamotrigine for Ketamine Dependence Trial | Biotech Hunter | Biotech Hunter